A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,003,138 shares of GH stock, worth $31.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,003,138
Previous 1,309,431 23.39%
Holding current value
$31.1 Million
Previous $37.8 Million 39.18%
% of portfolio
0.0%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$22.3 - $36.29 $6.83 Million - $11.1 Million
-306,293 Reduced 23.39%
1,003,138 $23 Million
Q2 2024

Aug 12, 2024

BUY
$16.07 - $31.84 $519,575 - $1.03 Million
32,332 Added 2.53%
1,309,431 $37.8 Million
Q1 2024

May 08, 2024

BUY
$17.13 - $26.91 $770,541 - $1.21 Million
44,982 Added 3.65%
1,277,099 $26.3 Million
Q4 2023

Feb 06, 2024

BUY
$21.58 - $29.5 $444,936 - $608,231
20,618 Added 1.7%
1,232,117 $33.3 Million
Q3 2023

Nov 08, 2023

BUY
$25.8 - $39.97 $7.56 Million - $11.7 Million
292,888 Added 31.88%
1,211,499 $35.9 Million
Q2 2023

Aug 09, 2023

BUY
$20.94 - $38.01 $6.55 Million - $11.9 Million
312,875 Added 51.65%
918,611 $32.9 Million
Q1 2023

May 11, 2023

BUY
$22.92 - $33.76 $120,421 - $177,375
5,254 Added 0.87%
605,736 $14.2 Million
Q4 2022

Feb 13, 2023

BUY
$25.44 - $59.78 $603,258 - $1.42 Million
23,713 Added 4.11%
600,482 $16.3 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $352,947 - $493,124
8,084 Added 1.42%
576,769 $31 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $335,810 - $901,282
11,652 Added 2.09%
568,685 $22.9 Million
Q1 2022

May 13, 2022

BUY
$48.25 - $100.49 $607,950 - $1.27 Million
12,600 Added 2.31%
557,033 $36.9 Million
Q4 2021

Feb 11, 2022

BUY
$88.71 - $120.43 $1.19 Million - $1.62 Million
13,450 Added 2.53%
544,433 $54.5 Million
Q3 2021

Nov 16, 2021

BUY
$98.77 - $132.17 $9.22 Million - $12.3 Million
93,306 Added 21.32%
530,983 $66.4 Million
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $1.57 Million - $2.37 Million
14,293 Added 3.38%
437,677 $54.4 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $339,450 - $478,555
2,672 Added 0.64%
423,384 $64.6 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $4.09 Million - $5.57 Million
40,959 Added 10.79%
420,712 $54.2 Million
Q3 2020

Nov 13, 2020

BUY
$80.32 - $111.8 $10.1 Million - $14 Million
125,620 Added 49.43%
379,753 $42.4 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $3.76 Million - $6.06 Million
62,145 Added 32.37%
254,133 $20.6 Million
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $1.06 Million - $1.6 Million
17,998 Added 10.34%
191,988 $13.4 Million
Q4 2019

Feb 07, 2020

BUY
$59.49 - $82.78 $229,036 - $318,703
3,850 Added 2.26%
173,990 $13.6 Million
Q3 2019

Nov 08, 2019

BUY
$62.59 - $110.3 $1.52 Million - $2.67 Million
24,214 Added 16.59%
170,140 $10.9 Million
Q2 2019

Aug 09, 2019

BUY
$63.94 - $91.11 $4.44 Million - $6.32 Million
69,363 Added 90.6%
145,926 $12.6 Million
Q1 2019

May 14, 2019

BUY
$34.3 - $97.98 $84,549 - $241,520
2,465 Added 3.33%
76,563 $5.87 Million
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $2.16 Million - $3.42 Million
74,098 New
74,098 $2.79 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.17B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.